One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v128.22.3502.3502
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 23 |
Affiliation: Dana-Farber Cancer Institute, University of Bologna, Churchill Hospital, Emory University, Huntsman Cancer Institute, IRCCS Humanitas Research Hospital, Fox Chase Cancer Center, Hospital Universitario Puerta de Hierro Majadahonda, Institut Català d'Oncologia, Cornell University, Bristol-Myers Squibb (United States), Fondazione Humanitas per la RicercaOutcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
